|
REVB Revelation Biosciences Inc 1810560 |
| Balance Sheet |
|
Current Assets
|
6,658,898 |
|
Assets
|
6,740,140 |
|
Current Liabilities
|
4,066,523 |
|
Liabilities
|
4,066,523 |
|
Equity
|
2,673,617 |
|
Shares Out
|
1,643,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-14,573,635 |
|
Investing Cash Flow
|
-36,860 |
| Market Analysis |
Market Cap
|
1,476,424 |
|
Price
|
0.40 |
|
BVPS
|
1.63 |
|
PB
|
0.25 |
|
EPS
|
-29.75 |
|
PS
|
0.08 |
|
FCF
|
-14,610,495 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view REVB documents filed with the SEC.
REVB Filings
Clear
